-transparent.png){kind=logo}
Eighty-six consecutive untreated adults with acute myelogenous leukemia were treated with a combination of Adriamycin, vincristine, prednisolone, Cytosine Arabinoside, and BCG. Complete remission was achieved in 39 (45%) patients; these patients were then allocated on an alternate basis to receive BCG and monthly chemotherapy with or without weekly irradiated allogeneic blast cells. The median duration of remission was eight months and was the same for both groups. The median survival of those achieving complete remission was 19 months compared with two months for those not achieving complete remission. Nine patients are still alive without relapse and five of these patients have been disease free for more than three years.
T A Lister, and
J M Whitehouse, and
R T Oliver, and
R Bell, and
S A Johnson, and
P F Wrigley, and
J M Ford, and
M H Cullen, and
W Gregory, and
A M Paxton, and
J S Malpas
January 1975,
Bibliotheca haematologica,
T A Lister, and
J M Whitehouse, and
R T Oliver, and
R Bell, and
S A Johnson, and
P F Wrigley, and
J M Ford, and
M H Cullen, and
W Gregory, and
A M Paxton, and
J S Malpas
June 1981,
Annals of internal medicine,
T A Lister, and
J M Whitehouse, and
R T Oliver, and
R Bell, and
S A Johnson, and
P F Wrigley, and
J M Ford, and
M H Cullen, and
W Gregory, and
A M Paxton, and
J S Malpas
January 2005,
Current hematology reports,
T A Lister, and
J M Whitehouse, and
R T Oliver, and
R Bell, and
S A Johnson, and
P F Wrigley, and
J M Ford, and
M H Cullen, and
W Gregory, and
A M Paxton, and
J S Malpas
October 1974,
Cancer,
T A Lister, and
J M Whitehouse, and
R T Oliver, and
R Bell, and
S A Johnson, and
P F Wrigley, and
J M Ford, and
M H Cullen, and
W Gregory, and
A M Paxton, and
J S Malpas
December 1973,
National Cancer Institute monograph,
T A Lister, and
J M Whitehouse, and
R T Oliver, and
R Bell, and
S A Johnson, and
P F Wrigley, and
J M Ford, and
M H Cullen, and
W Gregory, and
A M Paxton, and
J S Malpas
September 1998,
Leukemia,
T A Lister, and
J M Whitehouse, and
R T Oliver, and
R Bell, and
S A Johnson, and
P F Wrigley, and
J M Ford, and
M H Cullen, and
W Gregory, and
A M Paxton, and
J S Malpas
January 1982,
Nouvelle revue francaise d'hematologie,
T A Lister, and
J M Whitehouse, and
R T Oliver, and
R Bell, and
S A Johnson, and
P F Wrigley, and
J M Ford, and
M H Cullen, and
W Gregory, and
A M Paxton, and
J S Malpas
September 1983,
Archives of internal medicine,
T A Lister, and
J M Whitehouse, and
R T Oliver, and
R Bell, and
S A Johnson, and
P F Wrigley, and
J M Ford, and
M H Cullen, and
W Gregory, and
A M Paxton, and
J S Malpas
November 1981,
Cancer,
T A Lister, and
J M Whitehouse, and
R T Oliver, and
R Bell, and
S A Johnson, and
P F Wrigley, and
J M Ford, and
M H Cullen, and
W Gregory, and
A M Paxton, and
J S Malpas
January 1990,
Haematology and blood transfusion,
